Active: Cerebrospinal fluid AB1-42 levels Clear all

GWAS 2019-08-01

Genome-wide association study identifies CBFA2T3 affecting the rate of CSF Aβ42 decline in non-demented elders.

Dou KX, Zhang C et al.

Aging (Albany NY)

Brain amyloid deposition is an early pathological event in Alzheimer's disease (AD), and abnormally ...

Annualised percent change of cerebrospinal fluid AB1-42 levels

321

Participants

N/A

Studies

Details PubMed

GWAS 2018-09-24

Genome-Wide Association and Mechanistic Studies Indicate That Immune Response Contributes to Alzheimer's Disease Development.

Liu C, Chyr J et al.

Front Genet

Alzheimer's disease (AD) is the most common cause of dementia. Although genome-wide association stud...

Cerebrospinal fluid AB1-42 levels

812

Participants

N/A

Studies

Details PubMed

GWAS 2017-02-28

Genome-wide association study identifies four novel loci associated with Alzheimer's endophenotypes and disease modifiers.

Deming Y, Li Z et al.

Acta Neuropathol

More than 20 genetic loci have been associated with risk for Alzheimer's disease (AD), but reported ...

Cerebrospinal fluid AB1-42 levels

3149

Participants

N/A

Studies

Details PubMed

Title

Author

Journal

Disease/Trait

Date

Actions

Genome-wide association study identifies CBFA2T3 affecting the rate of CSF Aβ42 decline in non-demented elders.

Dou KX, Zhang C et al.

Aging (Albany NY)

Annualised percent change of cerebrospinal fluid AB1-42 levels

2019-08-01

Genome-Wide Association and Mechanistic Studies Indicate That Immune Response Contributes to Alzheimer's Disease Development.

Liu C, Chyr J et al.

Front Genet

Cerebrospinal fluid AB1-42 levels

2018-09-24

Genome-wide association study identifies four novel loci associated with Alzheimer's endophenotypes and disease modifiers.

Deming Y, Li Z et al.

Acta Neuropathol

Cerebrospinal fluid AB1-42 levels

2017-02-28